Quantcast
Last updated on April 18, 2014 at 17:24 EDT

ZERONA® Laser Proves a Success in Munich

July 24, 2012

ABINGDON, England, July 25, 2012 /PRNewswire/ –

Initial reports from Munich highlight positive results with the ZERONA laser

Trials of the non-invasive ZERONA(R) laser, manufactured by ERCHONIA in Munich,
Germany, have demonstrated the significant body sculpting benefits of Low Level Laser
Technology (LLLT), according to leading dermatologist Dr Patricia Ogilvie. “The ZERONA
laser has a photochemical action, working on the parts of the body where fat is stored,
and has been FDA-cleared for the non-invasive circumferential reduction of the waist, hips
and thighs since 2010.”

(Logo:
http://photos.prnewswire.com/prnh/20120719/546037-a )

The ZERONA’s cold laser technology uses low energy lasers to release fat from cells
without destroying them, and this therapeutic approach delivers noticeable body contouring
results without elevating cholesterol or triglyceride levels. Dr Ogilvie described the
treatment: “In a series of 20 minute sessions, a laser beam is directed at the body at
waist level on both the patient’s front and back. After treatment, the fatty material
drains into the lymphatic system and is removed naturally by the body. As a result,
adjacent areas are also slimmed down and it is possible to achieve reductions in
circumference of more than 10 cm; tissue also appears significantly firmer afterwards.”

She added: “The procedure is totally painless – the patient feels absolutely nothing
during treatment – and there are no risks involved.” James Stringer, Vice President,
European Sales, at Primcogent Solutions, commented: “We are delighted that Dr Ogilvie is
having success with the ZERONA laser and look forward to seeing the results from the
trials she will be undertaking.”

Since these trials began, ERCHONIA has released the complementary ZERONA AD, which
received US FDA clearance for the safe and effective reduction of upper arm circumference
in May 2012.

For more information, visit http://www.primcogent.com.

About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products to the medical community
backed by a clear, logical and convincing scientific and clinical foundation. Primcogent
Solutions’ signature product, ZERONA, manufactured by Erchonia Medical, is the only
platform that is CE-marked and FDA cleared for the safe and effective simultaneous
reduction of fat from the hips, waist and thighs. Primcogent Solutions’ revolutionary
non-invasive body contouring technology, along with its unique physician business model,
enhances practice profitability by eliminating the risks associated with purchasing
capital equipment. For more information, visit http://www.primcogent.com.

About Erchonia
Erchonia is the global leader in low-level laser healthcare applications. Over the last 15
years Erchonia has been conducting research and development with the world’s leading
physicians to advance the science of low-level lasers. Prior to market introduction, all
Erchonia lasers are proven safe and effective through independent clinical trials.
Currently, thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate
pain, accelerate healing, and treat acne. For additional information, visit

http://www.erchonia.com

[http://us.lrd.yahoo.com/_ylt=AsywZ8taMfxa4vwTo9ddUVQEKekE;_ylu=X3oDMTFqZG1vZW1rBG1pdANBcnRpY2xlIEJvZHkEcG9zAzcEc2VjA01lZGlhQXJ0aWNsZUJvZHlBc3NlbWJseQ--;_ylg=X3oDMTNwa2dpYmpiBGludGwDdXMEbGFuZwNlbi11cwRwc3RhaWQDYmM3NTU1NTUtNTZkOS0zZDVhLTk0YTYtOGEzYjRmNWQ5YjhmBHBzdGNhdANQb2xpdGljc3xQb2xpdGljcyUyRlByZXNzJTI1MjBSZWxlYXNlcwRwdANzdG9yeXBhZ2U-;_ylv=0/SIG=11c7i80sl/EXP=1339080730/**http%3A/www.erchonia.com ]
.

        For more information, contact Primcogent Solutions,
        20 Milton Park
        Abingdon
        Oxon
        OX14 4SH
        Tel: +44(0)1235-841590
        Email: sales@primcogent.com

http://www.primcogent.com

        (c) 2012 kdm communications limited


    Photo: 

http://photos.prnewswire.com/prnh/20120719/546037-a

SOURCE Primcogent Solutions


Source: PR Newswire